ABBLO PHARMA ApS: Financial statements 2019
CVR: 34080534
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 306,373 and a net result of DKK 100,475 compared with DKK 12,115 the year before. That is an increase of 110.5% compared with the year before. Equity in the 2019 report amounted to DKK -1,128,263. The company had 1 employee in the financial year.
- Gross Profit
- DKK 306,373
- Profit/Loss
- DKK 100,475
- Equity
- DKK -1,128,263
- Total Assets
- DKK 516,095
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 306 t. | 100 t. | -1.1 mio. | 1 |
| 2018 | - | 146 t. | 12 t. | -1.2 mio. | 1 |
| 2017 | - | 120 t. | -84 t. | -1.2 mio. | 1 |
| 2016 | - | -217 t. | -380 t. | -1.2 mio. | 1 |
| 2014 | - | -126 t. | 2 mio. | -215 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ABBLO PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 145,533, and the net result was DKK 12,115.
About ABBLO PHARMA ApS
ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The board consists of Mie Hjerrild Petersen (chair) and Nic Borch-Christensen. The company is owned by ABBLO S.à.r.l. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity in the 2025 report amounted to DKK -238,088.